Ключові слова: дифузні доброякісні дисплазії молочних залоз, міома матки, фітотерапія, Мастодинон. Conservative treatment within rehabilitation program can improve the quality of life in 46-52% of patients with concomitant diseases of mammary glands and genitals, reduce the number of relapses and progression of diffuse benign breast dysplasia in patients with uterine cancer from 44% to 13-18%. This tactic helps eliminate a hormonal imbalance, improving the breast status (by ultrasound data). Since no significant differences in the effectiveness of hormonal and herbal rehabilitation have been identified, the choice of a particular drug should depend on the clinical situation. Effectiveness of the preparation based on Agnus castus Mastodynon in the study was comparable to hormonal agents in terms of improving the quality of life and prevention of progression of benign breast diseases. BREAST AND GYNECOLOGIC DISEASES: FROM COMMUNITY PATHOGENETIC VIEWS TO PRACTICAL SOLUTIONS VE

Objective. To improve the reproductive health of women with benign breast dysplasia (BBD) and uterine myoma, by elaborating a differentiated approach to preventing and treating comorbid diseases.Subject and methods. The investigation included 175 women with concomitant genital diseases and BBD who were treated at the Gynecology Unit of the City Clinical Hospital No. 12, Moscow. The results of their examination and differentiated treatment for comorbid diseases of the uterus and breast were analyzed.Results. The altered ratio of steroid hormone levels as absolute or relative hyperestrogenemia underlies the pathogenesis of BBD in women with uterine myoma. The elaborated differentiated approach allows quality of life to be improved of 43.4% of patients with combined diseases of the mammary glands and genitals, to reduce the progression and recurrence of BBD in patients with uterine myoma from 36.7 to 15.9%.Conclusion. The findings strongly suggest that the women of this category must form a special follow-up gynecological group and their treatment must be a preventive measure against the progression and recurrence of BBD.

No abstract

No abstract

No abstract